tirzepatide 2.5 mg/0.5 ml injection Zepbound (single-dose vial) Images It is used to help improve blood sugar control in adults with type 2 diabetes Tirzepatide 2.5mg Kwikpen - Mounjaro

Neuroinflammation 18 , 252 (2021)

The moment we see obesity as a chronic disease, not a choice, everything changes like diagnosis, treatment, and empathy

Biologic agents targeting TNF- (such as adalimumab, etanercept, infliximab), IL-17 (secukinumab, ixekizumab), or IL-23 (guselkumab, risankizumab) work via immune modulation and do not share metabolic pathways with tirzepatide

What to Expect in Month 1 Appetite changes: Noticeable suppression begins week 3-4 for most Mild nausea: 40% experience some nausea, usually mild Injection site reactions: Redness, itching, or mild pain at injection site (14% of patients) Fatigue: Some patients report low energy as body adjusts Bowel changes: Either constipation or looser stools as medication affects gut motility 4 Essential Strategies for Month 1 1